Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 New Schizophrenia Treatments Address Unmet Clinical Needs.

Literature DB >> 28163559

New Schizophrenia Treatments Address Unmet Clinical Needs.

Abstract

We present several novel drugs in development for enhancing cognition, treating negative symptoms, and providing improved options for treatment-resistant patients. Drug makers aim to enhance safety profiles and increase patient compliance to therapy.

Entities: Disease Species

Year: 2017 PMID： 28163559 PMCID： PMC5265239

Source DB: PubMed Journal: P T ISSN： 1052-1372

12 in total

Review 1. The new genetics of schizophrenia.

Authors: Colm McDonald; Kieran C Murphy
Journal: Psychiatr Clin North Am Date: 2003-03

Review 2. Practice guideline for the treatment of patients with schizophrenia, second edition.

Authors: Anthony F Lehman; Jeffrey A Lieberman; Lisa B Dixon; Thomas H McGlashan; Alexander L Miller; Diana O Perkins; Julie Kreyenbuhl
Journal: Am J Psychiatry Date: 2004-02 Impact factor: 18.112

Review 3. Risk factors for relapse following treatment for first episode psychosis: a systematic review and meta-analysis of longitudinal studies.

Authors: M Alvarez-Jimenez; A Priede; S E Hetrick; S Bendall; E Killackey; A G Parker; P D McGorry; J F Gleeson
Journal: Schizophr Res Date: 2012-06-01 Impact factor: 4.939

Review 4. The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia.

Authors: J D Jentsch; R H Roth
Journal: Neuropsychopharmacology Date: 1999-03 Impact factor: 7.853

Review 5. The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements.

Authors: Robert W Buchanan; Julie Kreyenbuhl; Deanna L Kelly; Jason M Noel; Douglas L Boggs; Bernard A Fischer; Seth Himelhoch; Beverly Fang; Eunice Peterson; Patrick R Aquino; William Keller
Journal: Schizophr Bull Date: 2009-12-02 Impact factor: 9.306

6. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis.

Authors: Stefan Leucht; Caroline Corves; Dieter Arbter; Rolf R Engel; Chunbo Li; John M Davis
Journal: Lancet Date: 2008-12-06 Impact factor: 79.321

Review 7. Clozapine-induced seizures: recognition and treatment.

Authors: Jason Wong; Nicholas Delva
Journal: Can J Psychiatry Date: 2007-07 Impact factor: 4.356

8. Add-on treatment of benzoate for schizophrenia: a randomized, double-blind, placebo-controlled trial of D-amino acid oxidase inhibitor.

Authors: Hsien-Yuan Lane; Ching-Hua Lin; Michael F Green; Gerhard Hellemann; Chih-Chia Huang; Po-Wei Chen; Rene Tun; Yue-Cung Chang; Guochuan E Tsai
Journal: JAMA Psychiatry Date: 2013-12 Impact factor: 21.596

3. Physiologically Based Modeling Approach to Predict Dopamine D2 Receptor Occupancy of Antipsychotics in Brain: Translation From Rat to Human.

Authors: Yin Cheong Wong; Maddalena Centanni; Elizabeth C M de Lange
Journal: J Clin Pharmacol Date: 2019-01-24 Impact factor: 3.126

3 in total